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Expression of dominant-negative and chimeric subunits reveals
an essential role for 1 integrin during myelination
Joa˜o B. Relvas*, Anna Setzu*, Wia Baron*, Philip C. Buttery*‡,
Susan E. LaFlamme§, Robin J.M. Franklin† and Charles ffrench-Constant*
Myelination represents a remarkable example of cell Results and discussion
specialization and cell-cell interaction in To examine the role of 1 integrin in myelin sheath
development. During this process, axons are wrapped formation, we used either function-blocking antibodies
by concentric layers of cell membrane derived either or the expression of a dominant-negative 1 chimera con-
from central nervous system (CNS) oligodendrocytes taining the extracellular and transmembrane domains of
or peripheral nervous system Schwann cells. In the the small nonsignaling subunit of the interleukin 2 recep-
CNS, oligodendrocytes elaborate a membranous tor fused with the cytoplasmic domain of the 1 integrin
extension with an area of more than 1000 times that subunit (IL2R1). Such single  integrin cytoplasmic do-
of the cell body [1]. The mechanisms regulating this mains can function in a dominant-negative fashion to in-
change in cell shape remain poorly understood. hibit endogenous integrin function in cell adhesion,
Signaling mechanisms regulated by cell surface spreading, migration, and matrix assembly [6]. Consistent
adhesion receptors of the integrin family represent with our previous studies using a polyclonal antiserum
likely candidates. Integrins link the extracellular against 1 integrin, we found that a monoclonal 1 integ-
environment of the cell with both intracellular rin-blocking antibody present at 15 g/ml between days
signaling molecules and the cytoskeleton and have 2 and 5 inhibited myelin membrane formation on lami-
been shown to regulate the activity of GTPases nin-2 substrates (Figure 1). The cells did however maintain
implicated in the control of cell shape [2]. Our previous a network of myelin basic protein (MBP)-positive processes
work has established that oligodendrocytes and (Figure 1), confirming that the loss of myelin membranes
their precursors express a limited repertoire of did not reflect the loss of cell survival. In contrast, a
integrins [3, 4]. One of these, the 61 laminin function-blocking monoclonal antibody against 5 integ-
receptor, can interact with laminin-2 substrates to rin had no significant effect on membrane formation (Fig-
enhance oligodendrocyte myelin membrane
ure 1). Interestingly, we also found that a single applica-formation in cell culture [5]. However, these
tion of the 1-blocking antibody after 4 days of cultureexperiments do not address the important question
reduced the extent of myelin membrane formation 1 dayof integrin function during myelination in vivo, nor do
later to the same extent as experiments in which thethey define the respective roles of the  and 
antibody had been present for 3 days. This result suggestssubunits in the signaling pathways involved. Here, we
that 1 integrin function is required not only for myelinuse a dominant-negative approach to provide, for
membrane formation but also for their maintenance.the first time, evidence that 1 integrin function is
required for myelination in vivo and use chimeric
integrins to dissect apart the roles of the extracellular To examine the effects of the dominant-negative IL2R1
and cytoplasmic domains of the 6 subunit in the
construct, we first performed short-term adhesion assayssignaling pathways of myelination.
on laminin-2 substrates to confirm inhibition of the func-
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Figure 1
Myelin membrane formation assays in the presence of integrin-blocking software (Openlab, Improvision, and NIH image 1.61). (a) and (b)
antibodies. Oligodendrocyte precursors, obtained by mechanical show control cells after 5 and 2 days in culture, respectively, while
dissociation from cultures of newborn rat brains, were first expanded (c) and (d) show the effect of the function-blocking monoclonal anti-
in SATO medium containing platelet-derived growth factor (PDGF, 10 1 antibody (clone Ha2/5, Pharmingen) added from (c) days 2–5 or (d)
ng/ml) and fibroblast growth factor-2 (FGF-2, 10 ng/ml), and were only at day 4. (e) and (f) show the lack of effect of the anti-5 function-
then plated on laminin-2 substrates and allowed to differentiate for blocking monoclonal antibody (clone P1F6, Chemicon) added at
5 days in SATO medium [3] containing 0.5% fetal calf serum (FCS). (e) day 2 or (f) day 4. The graph shows the percentage of myelin
The extent of myelin membrane formation was then assessed by membrane formation as compared with control cells after 5 days, with
immunocytochemistry, using an antibody against myelin basic protein results of three independent experiments in triplicate expressed as
(MBP) (clone 12, Serotec), and quantified using image analysis mean  SD. An asterisk indicates p  0.025 (Student’s t test).
shown). This confirms that the expression of the different ited by the X-irradiation, any observed remyelination of
the axons within the lesion can only be carried out byconstructs did not alter the timing of differentiation or
the survival of the infected cells under the growth factor the transplanted oligodendrocyte progenitors. This sys-
tem therefore provides an assay to estimate the myelina-conditions used in this study.
tion potential of the transplanted cells following genetic
manipulation.These in vitro experiments with the dominant-negative
1 constructs confirm our previous [5] and present obser-
vations using blocking antibodies that 1 subunit function Three weeks after transplantation, animals were sacri-
ficed, and their spinal cords were removed and preparedis necessary for myelin membrane formation in cell cul-
ture. They predict that cells lacking 1 function in vivo for light and electron microscopy analysis. In animals
transplanted with IL2R1-expressing cells, a high propor-will show deficiencies in myelination, but the early em-
bryonic lethality of the 1 null mouse [7, 8] precludes tion of axons remained demyelinated when compared
with control transplants. The survival of transplanted cellsthe use of this mouse to study myelination. We therefore
took an alternative approach to the question of in vivo was apparently equivalent, as judged by the cellularity of
the lesions (Figure 3). The extent of remyelination infunction using the IL2R1 dominant-negative construct,
which has been used previously to reveal the roles played five control and eight IL2R1 transplanted spinal cords
was quantified using light microscopy on serial, toluidine-by 1 integrins in the development of the murine mam-
mary gland and osteoblast activity in vivo [9, 10]. We blue-stained semithin sections spanning the whole lesion.
To quantify each individual experiment, serial sectionstransplanted IL2R1 or control (vector-only)-expressing
oligodendrocyte progenitors into focal areas of demyelin- through each lesion were scored blind by two observers
and allocated a score of 0–3 (0  no myelin, 1  25%ation generated by the injection of the gliotoxin ethidium
bromide into the dorsal funiculus of the X-irradiated adult axons myelinated, 2  25%–75% axons myelinated, and
3  75% axons myelinated). In animals transplantedrat spinal cord [11]. As endogenous remyelination is inhib-
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Figure 2 Figure 3
The effect of the expression of the dominant-negative IL2R1 construct
on myelin membrane formation in vitro. The expression of the IL2R1
chimera in oligodendrocyte progenitors was achieved with the retroviral
pLIXN vector (Clontech Laboratories). Cells were grown and expanded
as described in Figure 1, then exposed to retroviral infection and
Remyelination of the dorsal funiculus of the spinal cord followingsubsequently maintained under antibiotic (G418) selection for a
transplantation of oligodendrocyte precursor cells expressing thetotal of 5 days. Under these conditions, immunocytochemistry revealed
IL2R1 construct or control cells. Cells were selected as describedthat at least 85% of the cells were expressing the transgene after infection
in the Figure 2 legend and then transplanted. (a) and (b) show lightwith the retroviruses (data not shown), and (a) the IL2R1 construct
micrographs from the dorsal funiculus of animals transplanted with (a)could also be seen in immunoprecipitations of cell lysates using an
control (vector-only) or (b) IL2R1-expressing cells. Note theanti-IL2R antibody. (b) and (c) show control and IL2R 1-expressing
evidence for remyelination in (a), in which thin myelin sheaths can becells, respectively, labeled with anti-MBP antibodies to show myelin
seen around the majority of axons. The field of view is taken nearmembrane formation as in Figure 1.
the edge of the lesion, and, consequently, a few axons with myelin
sheaths of normal thickness are also seen. No remyelination within
the lesion transplanted with IL2R1-expressing cells is seen in (b),
although the cellularity of the lesion is equivalent (transplanted cells
with IL21-expressing cells, the mean degree of myelina- are shown with white arrows). The scale bar indicates 50 m. The
difference in remyelination is seen at higher magnification in (c) andtion was significantly reduced from 1.7  0.15 to 1.05 
(d), which show electron micrographs of the transplanted lesions for0.2 (p  0.05).
(c) control and (d) IL2R1 cells, respectively. Note that thin myelin
sheaths can be seen around almost all axons in (c), which also contains
a cell body with the ultrastructural features of a myelinatingHaving defined a critical role for the 1 subunit of 61
oligodendrocyte (asterisk), while such sheaths are very rare in (d),in myelination in vivo, we next examined the role of the although cells with a precursor morphology can be identified
 subunit. To do this, we used a chimeric integrin ap- (asterisk). The magnification is 2700	.
proach as described by Sastry et al. [12]. We expressed
either a full-length human 5 subunit, a chimeric integrin
comprising the extracellular and transmembrane domains
the 1 cytoplasmic domain would suffice, 5ec/6cy1-,of the human 5 integrin subunit and the cytoplasmic
5
1-, or full-length 51-expressing cells would pro-domain of the human 6 integrin subunit (5ec/6cy)
duce myelin membranes similar in size to those seen in[11], or a cytoplasmic truncation of the human 5 chain
wild-type cells on laminin-2 substrates. If, in contrast, thefollowing the GFFKR motif (5
). The rationale for this
6 cytoplasmic domain was implicated in the process,experiment was as follows. The human  integrin sub-
5ec/6cy1 would form more myelin than 5
1.units will form by heterodimerization with the endoge-
nous rat 1 integrin subunit, functional hybrid integrin
receptors that can be detected by human 5-specific anti- The expression of the chimeric integrins (Figure 4) was
performed as before using the pLIXN vector. The capac-bodies. All of these hybrid integrins would be predicted
to bind to fibronectin through the identical 51 extracel- ity of the51,5
1, and5ec/6cy1 integrins to form
functional receptors and thus mediate oligodendrocytelular domains. However, as a result of their distinct 
cytoplasmic domains, these cells will differ in any intracel- adhesion to fibronectin substrates was confirmed by short-
term adhesion assays. All infected cells showed greaterlular signaling process downstream of individual  cyto-
plasmic domains. As a consequence, if differentiation adhesion to fibronectin (p  0.005, n  4) than control
“vector-only” cells. No significant differences in the num-assays are carried out on fibronectin substrates, two con-
trasting scenarios could occur. If signaling from the 6 ber of adherent cells was observed in these assays between
the three hybrid 5 integrins (for all, p  0.8, n  4).cytoplasmic domain was not involved, and signaling from
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Figure 4
The comparison of the effect of expression of
the 5 full-length, 5ec/6cy, and 5
, with
control vector-only constructs on the formation
of oligodendrocyte myelin membrane. After
retroviral infections and subsequent antibiotic
selection for 5 days, cells were plated on
fibronectin substrates and allowed to
differentiate in SATO medium containing
0.5% FCS. As in Figure 1, after 5 days of
differentiation, the cell cultures were fixed,
stained for myelin basic protein (MBP), and
the extent of myelin membrane formation was
quantified using image analysis software. (a)
The expression of the 5 chains on the surface
of the cell as assessed by
immunoprecipitation. (b–e) Cells infected
with full-length 5, 5ec/6cy, 5
, and
vector-only, respectively. The results are
quantified in (f), expressed as a percentage
of the result of the full-length 5 control to
show the significant difference between the
vector-only control and all the chimera-
expressing cells, but not between each of the
different chimera-expressing cells. The
double asterisk indicates p  0.005
(Student’s t test).
The expression of 5, a5
, and 5ec/6cy also had no ing and regulate the expression of genes that require
integrin function for their normal expression [13, 14]. Itsignificant effect on the state of differentiation of the
oligodendrocyte cultures, as determined by the time of appears that the role of the 6 subunit in myelin sheet
formation is to simply define the extracellular ligand-appearance and proportion of MBP-positive cells (data
not shown). This is consistent with a lack of effect on the binding specificity of 1 integrins; in this case, to laminins
present on at least some cell types whose axons are my-timing of differentiation observedwith the use of different
substrates [5] or function-blocking antibodies and domi- elinated in the CNS [15]. Switching the  subunit there-
fore changes the ligand specificity for myelination, andnant-negative 1 constructs as described above.
the manipulation of  subunit expression may provide a
strategy for enhancing repair following CNS transplanta-Oligodendrocyte cell cultures expressing either full-
tion of glial precursor cells by increasing their ability tolength 51, 5
1, and 5ec/6cy1 integrins and
bind to extracellular matrix molecules upregulated in thegrown on fibronectin substrates produced larger myelin
damaged CNS.membranes than control vector-only-infected cells (p 
0.005, n  4) (Figure 4). Importantly, this increase in
In contrast to myelination, 6 cytoplasmic domain-spe-myelin membrane formation on fibronectin was now com-
cific signaling pathways have been identified in otherparable to that seen in control cells grown on laminin-2
experimental paradigms. Sastry et al. reported that thesubstrates. This confirms the prediction of our experimen-
integrin-mediated cell cycle withdrawal and the onsettal strategy that the expression of the 5 extracellular
of terminal differentiation in muscle cells are controlleddomain leads to a switch in the substrate specificity for
independently by the 5 and 6 cytoplasmic domainsmyelin membrane formation. However, no significant dif-
[12]. The 6A, but not the 6B, cytoplasmic domain willference in membrane formation was observed between
trigger MAP kinase activation in macrophages when ad-the full-length 51, 5
1, and 5ec/6cy1-express-
hering to laminin substrates [16]. Our own work on oligo-ing oligodendrocytes (for all, p  0.5, n  4) (Figure 4),
dendrocyte survival signaling has revealed a critical roleindicating that signaling from the 6 cytoplasmic domain
for the 6 cytoplasmic domain (W. Baron et al., unpub-is not essential for this process and that signaling from
lished data). Taken together, these observations show thatthe1 cytoplasmic domain alone is sufficient for oligoden-
61 signalingmechanisms are both cell-type and contextdrocyte myelin formation. These results indicate no es-
dependent.sential role for the  cytoplasmic domain in myelin mem-
brane formation. They are therefore consistent with
studies in Drosophila showing that clustering of the  Several potential binding partners for the 1 cytoplasmic
tail have been identified [17]. These include actin-bind-cytoplasmic domain is sufficient to mimic integrin signal-
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mediators of morphogenesis in Drosophila. Dev Biol 2000,ing proteins such as talin, filamin, or -actinin; signaling
223:1-16.
proteins such as the integrin-linked kinase (ILK) and the 15. Powell SK, Williams CC, Nomizu M, Yamada Y, Kleinman HK:
Laminin-like proteins are differentially regulated duringfocal adhesion kinase (FAK); and adaptor proteins such as
cerebellar development and stimulate granule cell neuritepaxillin (which can in turn bind to several other molecules outgrowth in vitro. J Neurosci Res 1998, 54:233-247.
such as FAK, Src, and the p21-activated kinase [PAK]). 16. Wei J, Shaw LM, Mercurio AM: Regulation of mitogen-activated
protein kinase activation by the cytoplasmic domain of theIn addition, other molecules may not associate directly
alpha6 integrin subunit. J Biol Chem 1998, 273:5903-5907.
with the 1 cytoplasmic tail but are involved with 1 17. Liu S, Calderwood DA, Ginsberg MH: Integrin cytoplasmic
domain-binding proteins. J Cell Sci 2000, 113:3563-3571.signaling. In a recent report, Berrier and colleagues re-
18. Berrier AL, Mastrangelo AM, Downward J, Ginsberg M, LaFlammeported that R-Ras, PI 3-kinase, PKC, and Rac1, proteins SE: Activated R-ras, Rac1, PI 3-kinase and PKCepsilon can
known to positively regulate cell spreading, do so through each restore cell spreading inhibited by isolated integrin
beta1 cytoplasmic domains. J Cell Biol 2000, 151:1549-1560.a mechanism involving the integrin 1 cytoplasmic do-
main [18]. Our results, showing for the first time an essen-
tial role of 1 integrins in myelination, as revealed by
genetic manipulation of cells ex vivo prior to transplanta-
tion, suggest that some of these potential partners of 1
are likely to be critical regulators of the dramatic cell
shape changes during myelination.
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